Dr. Matthew Bott, MD

Claim this profile

Memorial Sloan Kettering

Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
2 reported clinical trials
5 drugs studied

Area of expertise

1Lung Cancer
Matthew Bott, MD has run 1 trial for Lung Cancer. Some of their research focus areas include:
Stage I
Stage III
Stage II
2Non-Small Cell Lung Cancer
Matthew Bott, MD has run 1 trial for Non-Small Cell Lung Cancer. Some of their research focus areas include:
Stage I
Stage III
Stage II

Affiliated Hospitals

Image of trial facility.
Memorial Sloan Kettering
Image of trial facility.
Memorial Sloan Kettering Cancer Center (All Protocol Activities)

Clinical Trials Matthew Bott, MD is currently running

More about Matthew Bott, MD

Clinical Trial Related2 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 1 Active Clinical Trial
Treatments Matthew Bott, MD has experience with
  • Carboplatin
  • Nivolumab
  • Nivolumab And Ipilimumab
  • Paclitaxel
  • NovoTTF-200T System
Breakdown of trials Matthew Bott, MD has run
Non-Small Cell Lung Cancer
Lung Adenocarcinoma

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
What does Matthew Bott, MD specialize in?
Is Matthew Bott, MD currently recruiting for clinical trials?
Are there any treatments that Matthew Bott, MD has studied deeply?
What is the best way to schedule an appointment with Matthew Bott, MD?
What is the office address of Matthew Bott, MD?
Is there any support for travel costs?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security